The NHLBI Catalyze Product Definition Grant supports the identification and characterization of potential therapeutic candidates for heart, lung, blood, and sleep diseases. This grant aims to provide early translational support to advance projects towards meeting entry criteria for the NHLBI Catalyze Preclinical program or attracting independent development support from other federal or private partners for preclinical optimization and development of therapeutic agents. Clinical trials are not allowed under this FOA. Closing date for applications is August 11, 2021.
Opportunity ID: 320420
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-20-023 |
| Funding Opportunity Title: | Catalyze: Product Definition for Small Molecules and Biologics – Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 13 |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 09, 2019 |
| Last Updated Date: | Sep 09, 2019 |
| Original Closing Date for Applications: | Aug 11, 2021 |
| Current Closing Date for Applications: | Aug 11, 2021 |
| Archive Date: | Sep 16, 2021 |
| Estimated Total Program Funding: | $3,800,000 |
| Award Ceiling: | $350,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Native American tribal governments (Federally recognized) Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses County governments Small businesses City or township governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify and characterize potential therapeutic candidates to treat heart, lung, blood, and sleep diseases and disorders. This FOA is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical optimization and development of therapeutic agents. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-023.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260350 | Oct 08, 2019 | Aug 11, 2021 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00254720 | Oct 08, 2019 | May 24, 2020 | View |
Package 1
Mandatory forms
320420 RR_SF424_2_0-2.0.pdf
320420 PHS398_CoverPageSupplement_5_0-5.0.pdf
320420 RR_OtherProjectInfo_1_4-1.4.pdf
320420 PerformanceSite_2_0-2.0.pdf
320420 RR_KeyPersonExpanded_2_0-2.0.pdf
320420 RR_Budget_1_4-1.4.pdf
320420 PHS398_ResearchPlan_4_0-4.0.pdf
320420 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
320420 RR_SubawardBudget30_1_4-1.4.pdf
320420 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
320420 RR_SF424_2_0-2.0.pdf
320420 PHS398_CoverPageSupplement_4_0-4.0.pdf
320420 RR_OtherProjectInfo_1_4-1.4.pdf
320420 PerformanceSite_2_0-2.0.pdf
320420 RR_KeyPersonExpanded_2_0-2.0.pdf
320420 RR_Budget_1_4-1.4.pdf
320420 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
320420 RR_SubawardBudget30_1_4-1.4.pdf
320420 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
